Your browser doesn't support javascript.
loading
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).
Franchimont, D; Ferrante, M; Louis, E; De Vos, M; Dewit, O; Van Hootegem, P; Moreels, T; Liefferinckx, C; Bossuyt, P; Baert, F; Rahier, J F; Vermeire, S.
Afiliação
  • Franchimont D; Department of Gastroenterology, Hopital Erasme Brussels, Belgium.
  • Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Belgium.
  • Louis E; Department of Gastroenterology, Centre Hospitalier Universitaire de Liege, Belgium.
  • De Vos M; Department of Gastroenterology - Ghent University Hospital - Ghent University, Belgium.
  • Dewit O; Department of Gastroenterology, Cliniques Universitaires Saint-Luc UCL Bruxelles, Belgium.
  • Van Hootegem P; Department of Gastroenterology, AZ Sint Lucas Brugge, Belgium.
  • Moreels T; Department of Gastroenterology, Cliniques Universitaires Saint-Luc UCL Bruxelles, Belgium.
  • Liefferinckx C; Department of Gastroenterology, Hopital Erasme Brussels, Belgium.
  • Bossuyt P; Department of Gastroenterology, Imeldaziekenhuis, Bonheiden, Belgium.
  • Baert F; Department of Gastroenterology, AZ Delta Roeselare, Belgium.
  • Rahier JF; Department of Gastroenterology, CHU UCL Mont-Godinne, Belgium.
  • Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Belgium.
Acta Gastroenterol Belg ; 81(1): 49-53, 2018.
Article em En | MEDLINE | ID: mdl-29562378
Buscar no Google
Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Medicamentos Biossimilares Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Medicamentos Biossimilares Idioma: En Ano de publicação: 2018 Tipo de documento: Article